Related Experiment Video
Updated: Aug 11, 2026
A Training and Testing System for Performing Vascular Reconstruction In Vitro
Published on: October 26, 2019
[The best of vascular medicine in 2005]
C Mounier-Vehier1, D Stephan, F Becker
1Service de médecine vasculaire et HTA, Hôpital cardiologique, CHRU, 59037 Lille. cmouniervehier@chru-lille.fr
Insights
Vascular medicine research shows conflicting results on endoprostheses for abdominal aortic aneurysms and the utility of endothelial progenitor cells. New findings reveal a U-shaped curve for the Systolic Pressure Index and its link to cardiovascular complications.
Area of Science:
- Vascular Medicine
- Cardiovascular Research
- Clinical Practice
Background:
- Clinical practice in vascular medicine requires long-term evidence, which is often contradicted by short-term studies.
- Recent research highlights evolving understanding of cardiovascular markers and treatments.
Purpose of the Study:
- To review recent advancements and controversies in vascular medicine.
- To assess the current evidence for treatments and diagnostic markers in vascular diseases.
Main Methods:
- Review of recent clinical trials and fundamental research in vascular medicine.
- Analysis of data regarding endoprostheses for abdominal aortic aneurysms.
- Evaluation of endothelial progenitor cells as atherosclerosis markers.
- Assessment of ximelagatran's safety profile.
- Examination of the Systolic Pressure Index and its relationship with cardiovascular complications.
- Investigation of BNP as a marker for renal arterial stenosis.
- Consideration of treatment options for superficial femoral artery stenosis.
Main Results:
- Contradictory debates exist regarding the long-term benefits of endoprostheses for abdominal aortic aneurysms.
- Endothelial progenitor cells show potential as atherosclerosis markers, but their superiority over LDL-cholesterol is unproven.
- Ximelagatran, a direct thrombin antagonist, raised concerns due to reported hepatic enzyme elevations.
- The Systolic Pressure Index demonstrates a U-shaped correlation with cardiovascular complications.
- BNP may serve as a marker for hemodynamically significant renal arterial stenosis in specific patient groups.
- Evidence for active stents in superficial femoral artery stenosis remains inconclusive.
Conclusions:
- Vascular medicine is characterized by evolving and often contradictory findings, necessitating ongoing research.
- Further investigation is required to establish definitive treatment guidelines and diagnostic criteria.
- The clinical relevance of new markers and treatments needs long-term validation.
Abstract:
It is illusory to think that one year is long enough to establish all the truths that will guide our clinical practice in vascular medicine. On the contrary, one year was long enough to contradict what the preceding twelve months had set out to demonstrate. Consequently, promising trials in the treatment of abdominal aortic aneurysms by endoprostheses have been the object of contradictory debate with regards to the long-term benefits. In fundamental research, circulating progenitors of endothelial cells have been shown to be a marker of atherosclerosis, but is it a better marker than LDL-cholesterol values? The demonstration that these progenitors are of value in the treatment of essential ischaemia of the lower limbs is awaited. Finally, ximelagatran, a direct thrombin antagonist, seemed to have all the qualities of an ideal anticoagulant: easy to use, safe... until the report of raised hepatic enzymes, the clinical relevance of which remains to be determined. In the good news section: the Systolic Pressure Index, an unquestioned marker of arterial disease. Its reduction was known to be correlated with the prevalence of cardiovascular complications. However, it has now been shown that an increase in the index is also associated with cardiovascular complications, a real U-shaped curve. Renal arterial stenosis should be considered in patients with left ventricular failure presenting with flash pulmonary oedema. In the absence of cardiac pathology, BNP would seem to be a good biological marker of haemodynamically significant renal arterial stenosis. Finally, should superficial femoral artery stenosis be treated by an active stent. To date, there is no formal proof.
Related Concept Videos
01:20Overview of the Vascular System
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
01:19Imaging Studies VII: Vascular Imaging
01:16Vascular Spasm
01:20Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
01:27Peripheral Artery Disease III: Interprofessional Care